Clinical Trials on Evaluate the Safety and Efficacy of Apixaban in Germany
Total 640 results
-
Bristol-Myers SquibbActive, not recruiting
-
NovartisCompletedSuperficial Thrombophlebitis of the Upper LimbGermany
-
Heinrich-Heine University, DuesseldorfRecruiting
-
Gaia AGUniversity Hospital Schleswig-Holstein; Universität Duisburg-EssenRecruitingMultiple SclerosisGermany
-
University Medicine GreifswaldActive, not recruitingMultiple SclerosisGermany
-
Charite University, Berlin, GermanyTerminatedMultiple SclerosisGermany
-
University Hospital TuebingenUnknownSquamous Cell Carcinoma of the SkinGermany
-
Universitätsklinikum Hamburg-EppendorfCharite University, Berlin, Germany; Heinrich-Heine University, Duesseldorf; University... and other collaboratorsCompletedMultiple SclerosisGermany
-
Charite University, Berlin, GermanyActive, not recruiting
-
University of Erlangen-NürnbergNeurological Rehabilitation Center Quellenhof; ZTM Bad KissingenCompleted
-
Universitätsklinikum Hamburg-EppendorfUnknown
-
AIO-Studien-gGmbHTaiho Pharmaceutical Co., Ltd.; Nordic Pharma SASCompletedEsophageal Neoplasms | Gastric Adenocarcinoma | Esophageal Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Gastric Neoplasm | Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal JunctionGermany
-
BiogenActive, not recruiting
-
BiogenCompleted
-
Charite University, Berlin, GermanyCompleted
-
Charite University, Berlin, GermanyNovartis Germany GmbHCompletedMultiple SclerosisGermany
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Universitätsklinikum Hamburg-EppendorfGerman Federal Ministry of Education and ResearchCompletedMultiple SclerosisGermany
-
BiogenCompletedMultiple SclerosisGermany
-
Boston Scientific CorporationCompletedAtherosclerosis of Native Arteries of the ExtremitiesNew Zealand, Germany, Belgium, Australia, Austria
-
Charite University, Berlin, GermanyGenzyme, a Sanofi CompanyTerminatedMultiple Sclerosis | FatigueGermany
-
Charite University, Berlin, GermanyCompletedMultiple Sclerosis | FatigueGermany
-
University Hospital FreiburgLudwig-Maximilians - University of Munich; University Hospital Heidelberg; University... and other collaboratorsUnknownPrimary Non Hodgkin Lymphoma of the Central Nervous SystemGermany
-
Heidelberg UniversityCompletedSinonasal Malignancies | Adenocarcinoma and Squamous Cell Carcinoma of the Paranasal SinusesGermany
-
Ethicon, Inc.TerminatedPtosis of the Neck, Mid-face and/or JowlIsrael, France, Germany, United Kingdom
-
Ulrich KeilholzCharite University, Berlin, Germany; AstraZenecaCompletedSquamous Cell Carcinoma of the Head and NeckGermany
-
Medical Valley Digital Health Application Center...Celgene Corporation; University of Regensburg; Portabiles HealthCare Technologies... and other collaboratorsCompletedMultiple SclerosisGermany
-
Merck KGaA, Darmstadt, GermanyGesellschaft für Therapieforschung mbHCompleted
-
BayerCompleted
-
German Breast GroupCompleted
-
IDEA AGCompletedOsteoarthritis of the KneePoland, United Kingdom, Czech Republic, Germany
-
BayerCompleted
-
BayerCompleted
-
Charite University, Berlin, GermanyBrainswayCompletedMultiple SclerosisGermany
-
Merck KGaA, Darmstadt, GermanyMerck B.V., NetherlandsTerminated
-
Friedemann PaulTAIYO EUROPECompleted
-
University Hospital TuebingenUnknownSquamous Cell Carcinoma of the Head and NeckGermany
-
BiogenCompletedMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingGermany
-
Dr. med. Micha LoebermannCompletedMultiple Sclerosis, Relapsing-RemittingGermany
-
Charite University, Berlin, GermanyCompletedMultiple Sclerosis, Relapsing-RemittingGermany
-
Novartis PharmaceuticalsCompletedLong-term Safety of TIPItaly, Spain, Germany, United States, Australia, Canada, Hungary, Mexico, Argentina
-
Rehazentrum WilhelmshavenCompletedMultiple Sclerosis | FatigueGermany
-
Baxalta now part of ShireCompletedMalignant Solid Tumors | Metastatic Adenocarcinoma of the Colon or RectumGermany, United States
-
Probi ABCompleted
-
BayerCompleted
-
Universidad Autonoma de MadridCompletedAvascular Necrosis of the Femoral HeadItaly, France, Germany, Spain
-
University Hospital MuensterGenzyme, a Sanofi CompanyCompletedMultiple Sclerosis, Relapsing-RemittingGermany
-
BiogenTerminatedMultiple Sclerosis, Relapsing-RemittingGermany
-
BiogenCompletedMultiple SclerosisUnited States, Germany
-
Astellas Pharma Global Development, Inc.CompletedCLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction | CLDN18.2-positive Adenocarcinoma of Esophagus | CLDN18.2-positive Gastric AdenocarcinomaGermany, Latvia